Osteomyelitis Treatment Guidelines

Introduction to Osteomyelitis Treatment

• The Infectious Diseases Society of America (IDSA) recommends vancomycin, daptomycin, linezolid, TMP-SMX with rifampin, or clindamycin for MRSA osteomyelitis, but does not include beta-lactam/beta-lactamase inhibitor combinations like Zosyn 1, 3, 5

Standard Duration for Osteomyelitis Treatment

• A minimum 8-week course of antibiotic therapy is recommended for MRSA osteomyelitis, with consideration for additional 1-3 months of oral rifampin-based combination therapy for chronic infection or inadequate debridement 1, 3, 6
• Pediatric osteomyelitis requires 4-6 weeks of treatment 2, 4, 5

Surgical Considerations

• Surgical debridement and drainage of associated soft-tissue abscesses is the mainstay of therapy and should be performed whenever feasible 1, 3, 5

Monitoring and Adjustment

• Monitor inflammatory markers (ESR and/or CRP) to guide response to therapy 1, 3

Recommended Alternative Agents

• For MRSA osteomyelitis, consider vancomycin, daptomycin, or linezolid instead of Zosyn 1, 3, 6
• For MSSA osteomyelitis, consider nafcillin, oxacillin, or cefazolin instead of Zosyn 1